• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于监测、流行病学与结果(SEER)数据库的同步性结直肠癌患者的基于套索(LASSO)的生存预测模型

A LASSO-based survival prediction model for patients with synchronous colorectal carcinomas based on SEER.

作者信息

Xu Yuxin, Wang Xiaojie, Huang Ying, Ye Daoxiong, Chi Pan

机构信息

Department of Colorectal Surgery, Union Hospital, Fujian Medical University, Fuzhou, China.

出版信息

Transl Cancer Res. 2022 Aug;11(8):2795-2809. doi: 10.21037/tcr-20-1860.

DOI:10.21037/tcr-20-1860
PMID:36093555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9459507/
Abstract

BACKGROUND

The nomogram for postoperative prediction of overall survival (OS) in patients' synchronous colorectal carcinomas (SCC) was developed and validated by least absolute shrinkage and selection operator (LASSO)-based Cox regression.

METHODS

The data was obtained from the SEER database of patients diagnosed with colorectal cancer (CRC) more than one time between 2004 and 2013. Patients who had CRC more than 3 times or multiple metachronous primary carcinomas were excluded. The cut-off points for the continuous variable were identified by the K-adaptive partitioning algorithm and x-tile software. Using LASSO-based Cox regression, a model for predicting the OS of SCC was built, internally and externally validated, and measured through a calibration curve, C-index, Akaike information criterion (AIC), Bayesian information criterion (BIC), net reclassification improvement (NRI), integrated discrimination improvement (IDI), time-dependent receiver operating characteristic (timeROC), time-dependent area under curve (timeAUC), and decision curve analysis (DCA), and results compared to the model developed by the Cox regression.

RESULTS

Patients with SCC were found to be older, more often men, and likely to have a depth of invasion by T3. In addition, there were no significant differences between the model developed by LASSO-based Cox regression and the Cox regression in the C-index (0.712 and 0.710), AIC (33,420 and 33,431), BIC (4.49), IDI (0.002), NRI (-0.009), timeROC, and DCA. Besides, the model developed by LASSO-based Cox regression was found to perform better than the Cox regression in the timeAUC. Moreover, the model developed by LASSO-based Cox regression showed good C-index (0.712, 0.637, and 0.651), AIC (33,420, 34,043, and 33,994), BIC (1,178.76 and 1,098.57), IDI (-0.072 and -0.064), NRI (0.525 and 0.466), timeROC, timeAUC and had a larger net benefit compared to both the first time TNM staging and the combination of two times TNM staging.

CONCLUSIONS

This present study indicates that a close follow-up of older patients, male, and T3 should be made. Compared with the traditional Cox regression model, LASSO-based Cox regression decreases the variables of the model, avoids overfitting and collinearity and has clinical significance.

摘要

背景

通过基于最小绝对收缩和选择算子(LASSO)的Cox回归,开发并验证了用于预测同步性结直肠癌(SCC)患者术后总生存期(OS)的列线图。

方法

数据来自2004年至2013年间被诊断为结直肠癌(CRC)超过一次的患者的SEER数据库。排除患有超过3次CRC或多个异时性原发性癌的患者。通过K自适应划分算法和x-tile软件确定连续变量的截断点。使用基于LASSO的Cox回归构建预测SCC患者OS的模型,进行内部和外部验证,并通过校准曲线、C指数、赤池信息准则(AIC)、贝叶斯信息准则(BIC)、净重新分类改善(NRI)、综合判别改善(IDI)、时间依赖性受试者工作特征曲线(timeROC)、时间依赖性曲线下面积(timeAUC)和决策曲线分析(DCA)进行评估,并将结果与Cox回归开发的模型进行比较。

结果

发现SCC患者年龄较大,男性居多,且T3浸润深度的可能性较大。此外,基于LASSO的Cox回归开发的模型与Cox回归在C指数(0.712和0.710)、AIC(33420和33431)、BIC(4.49)、IDI(0.002)、NRI(-0.009)、timeROC和DCA方面无显著差异。此外,基于LASSO的Cox回归开发的模型在timeAUC方面表现优于Cox回归。此外,基于LASSO的Cox回归开发的模型显示出良好的C指数(0.712、0.637和0.651)、AIC(33420、34043和33994)、BIC(1178.76和1098.57)、IDI(-0.072和-0.064)、NRI(0.525和0.466)、timeROC、timeAUC,并且与首次TNM分期和两次TNM分期的组合相比,具有更大的净效益。

结论

本研究表明,应对年龄较大、男性和T3患者进行密切随访。与传统的Cox回归模型相比,基于LASSO的Cox回归减少了模型变量,避免了过度拟合和共线性,具有临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/bcf3bd196067/tcr-11-08-2795-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/400c661de4e5/tcr-11-08-2795-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/305fda2b4c3a/tcr-11-08-2795-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/846f07e0d6ca/tcr-11-08-2795-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/5592db41f3d3/tcr-11-08-2795-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/3a4d2a9a49a1/tcr-11-08-2795-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/1132fb68113f/tcr-11-08-2795-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/2111674879de/tcr-11-08-2795-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/e07d31be3b48/tcr-11-08-2795-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/bcf3bd196067/tcr-11-08-2795-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/400c661de4e5/tcr-11-08-2795-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/305fda2b4c3a/tcr-11-08-2795-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/846f07e0d6ca/tcr-11-08-2795-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/5592db41f3d3/tcr-11-08-2795-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/3a4d2a9a49a1/tcr-11-08-2795-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/1132fb68113f/tcr-11-08-2795-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/2111674879de/tcr-11-08-2795-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/e07d31be3b48/tcr-11-08-2795-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a68a/9459507/bcf3bd196067/tcr-11-08-2795-f9.jpg

相似文献

1
A LASSO-based survival prediction model for patients with synchronous colorectal carcinomas based on SEER.基于监测、流行病学与结果(SEER)数据库的同步性结直肠癌患者的基于套索(LASSO)的生存预测模型
Transl Cancer Res. 2022 Aug;11(8):2795-2809. doi: 10.21037/tcr-20-1860.
2
Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.开发和评估列线图和风险分层系统,以预测肝细胞癌患者的总生存率和癌症特异性生存率。
Clin Exp Med. 2024 Feb 28;24(1):44. doi: 10.1007/s10238-024-01296-1.
3
A prognostic nomogram integrating carcinoembryonic antigen levels for predicting overall survival in elderly patients with stage II-III colorectal cancer.一种整合癌胚抗原水平的预后列线图,用于预测老年II-III期结直肠癌患者的总生存期。
J Gastrointest Oncol. 2024 Feb 29;15(1):164-178. doi: 10.21037/jgo-23-863. Epub 2024 Feb 27.
4
Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.接受放化疗和手术的乳腺癌患者预后列线图的开发与验证:一项基于监测、流行病学和最终结果(SEER)数据库及两个中国队列的回顾性队列研究
Am J Cancer Res. 2023 Nov 15;13(11):5065-5081. eCollection 2023.
5
Constructing a prognostic model for colorectal cancer with synchronous liver metastases after preoperative chemotherapy: a study based on SEER and an external validation cohort.基于 SEER 和外部验证队列构建术前化疗后结直肠癌伴肝转移的预后模型: 一项研究。
Clin Transl Oncol. 2024 Dec;26(12):3169-3190. doi: 10.1007/s12094-024-03513-5. Epub 2024 Jun 4.
6
A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.一种基于新型 LASSO 算法的预后模型,可预测 M1a 期非小细胞肺癌患者的生存情况。
Cancer Med. 2022 Mar;11(6):1561-1572. doi: 10.1002/cam4.4560. Epub 2022 Feb 6.
7
Establishment of a Prognostic Nomogram for Cancer-Specific Survival in Patients With Base-of-Tongue Squamous Cell Carcinoma: A Retrospective Study Based on the SEER Database.基于 SEER 数据库的回顾性研究:建立预测舌底鳞癌患者癌症特异性生存的预后列线图。
Cancer Control. 2023 Jan-Dec;30:10732748231210733. doi: 10.1177/10732748231210733.
8
Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.基于 SEER 人群的研究:预测局部晚期乳腺癌患者总生存和癌症特异性生存的列线图的建立和验证。
Front Public Health. 2022 Sep 20;10:969030. doi: 10.3389/fpubh.2022.969030. eCollection 2022.
9
A novel risk classifier for predicting the overall survival of patients with thymic epithelial tumors based on the eighth edition of the TNM staging system: A population-based study.基于第八版 TNM 分期系统的新型胸腺瘤患者总生存风险分类器预测模型:一项基于人群的研究。
Front Endocrinol (Lausanne). 2022 Dec 6;13:1050364. doi: 10.3389/fendo.2022.1050364. eCollection 2022.
10
Clinical features and prognostic factors in patients diagnosed with lymphovascular invasion of testicular germ-cell tumors: Analysis based on the SEER database.睾丸生殖细胞肿瘤伴淋巴管侵犯患者的临床特征及预后因素:基于监测、流行病学和最终结果(SEER)数据库的分析
Front Oncol. 2023 Mar 3;13:1142441. doi: 10.3389/fonc.2023.1142441. eCollection 2023.

引用本文的文献

1
Decoding the PTTG family's contribution to LUAD pathogenesis: a comprehensive study on expression, epigenetics, and therapeutic interventions.解读垂体瘤转化基因(PTTG)家族对肺腺癌发病机制的贡献:关于表达、表观遗传学及治疗干预的综合研究
Hereditas. 2025 Aug 28;162(1):175. doi: 10.1186/s41065-025-00545-x.
2
Radiographic signature in apical periodontitis improves prediction of apical lesion healing through survival prediction model.根尖周炎的影像学特征通过生存预测模型改善了对根尖病变愈合的预测。
PLoS One. 2025 Jul 21;20(7):e0327970. doi: 10.1371/journal.pone.0327970. eCollection 2025.
3
Illuminating the role of VEGFA and EGFR in head and neck squamous cell carcinoma through the multi-omics data integration.

本文引用的文献

1
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
2
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.第八版 AJCC 癌症分期手册:继续从基于人群的方法向更“个体化”的癌症分期方法构建桥梁。
CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17.
3
New Perspectives in Multiple Primary Colorectal Cancer: A Surgical Approach.
通过多组学数据整合阐明VEGFA和EGFR在头颈部鳞状细胞癌中的作用。
Saudi Med J. 2025 Jul;46(7):768-780. doi: 10.15537/smj.2025.46.7.20240775.
4
Readmission After Ischemic Stroke in Ningxia, China, From 2017 to 2021: Retrospective Cohort Study.2017年至2021年中国宁夏缺血性中风后的再入院情况:回顾性队列研究
Interact J Med Res. 2025 Jul 3;14:e67522. doi: 10.2196/67522.
5
Development and validation of a 16-gene T-cell- related prognostic model in non-small cell lung cancer.非小细胞肺癌中16基因T细胞相关预后模型的开发与验证
Front Immunol. 2025 Apr 7;16:1566597. doi: 10.3389/fimmu.2025.1566597. eCollection 2025.
6
Identification and validation of matrix metalloproteinase hub genes as potential biomarkers for Skin Cutaneous Melanoma.鉴定和验证基质金属蛋白酶枢纽基因作为皮肤黑色素瘤的潜在生物标志物
Front Oncol. 2024 Oct 18;14:1471267. doi: 10.3389/fonc.2024.1471267. eCollection 2024.
7
Stigmasterol exerts antiglioma effects by regulating lipid metabolism.豆甾醇通过调节脂代谢发挥抗脑胶质瘤作用。
Mol Med Rep. 2024 Dec;30(6). doi: 10.3892/mmr.2024.13351. Epub 2024 Oct 4.
8
Females with diabetes have a higher risk of ischemic stroke readmission: a retrospective cohort study.女性糖尿病患者缺血性脑卒中再入院风险更高:一项回顾性队列研究。
BMC Public Health. 2024 Sep 12;24(1):2488. doi: 10.1186/s12889-024-20006-w.
9
Deciphering the role of wound healing genes in skin cutaneous melanoma: Insights into expression, methylation, mutations, and therapeutic implications.解析伤口愈合基因在皮肤黑色素瘤中的作用:表达、甲基化、突变及治疗意义。
Int Wound J. 2024 Apr;21(4):e14807. doi: 10.1111/iwj.14807.
10
Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).鉴定和验证 MMP 家族成员(MMP2、MMP9、MMP12 和 MMP16)作为肾透明细胞癌(KIRC)的治疗靶点和生物标志物。
Oncol Res. 2024 Mar 20;32(4):737-752. doi: 10.32604/or.2023.042925. eCollection 2024.
多原发性结直肠癌的新视角:一种手术方法
Digestion. 2016;94(2):57-65. doi: 10.1159/000448279. Epub 2016 Aug 5.
4
Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.基于影像组学的直肠癌淋巴结转移术前预测列线图模型的建立与验证。
J Clin Oncol. 2016 Jun 20;34(18):2157-64. doi: 10.1200/JCO.2015.65.9128. Epub 2016 May 2.
5
Nonparametric estimation of time-dependent ROC curves conditional on a continuous covariate.基于连续协变量的时间依赖型ROC曲线的非参数估计。
Stat Med. 2016 Mar 30;35(7):1090-102. doi: 10.1002/sim.6769. Epub 2015 Oct 20.
6
Nomograms in oncology: more than meets the eye.肿瘤学中的列线图:远不止表面所见。
Lancet Oncol. 2015 Apr;16(4):e173-80. doi: 10.1016/S1470-2045(14)71116-7.
7
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.个体预后或诊断多变量预测模型的透明报告(TRIPOD):TRIPOD声明
BJOG. 2015 Feb;122(3):434-43. doi: 10.1111/1471-0528.13244.
8
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.透明报告个体预后或诊断的多变量预测模型(TRIPOD):TRIPOD 声明。
Eur J Clin Invest. 2015 Feb;45(2):204-14. doi: 10.1111/eci.12376. Epub 2015 Jan 5.
9
Cancer survival: an overview of measures, uses, and interpretation.癌症生存率:测量方法、用途及解读概述
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):145-86. doi: 10.1093/jncimonographs/lgu024.
10
Calibration of risk prediction models: impact on decision-analytic performance.风险预测模型的校准:对决策分析性能的影响。
Med Decis Making. 2015 Feb;35(2):162-9. doi: 10.1177/0272989X14547233. Epub 2014 Aug 25.